2
项与 人脐带间充质干细胞疗法(重庆医科大学附属儿童医院) 相关的临床试验Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Premature Infants At High Risk For Bronchopulmonary
This study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in premature infants at high risk for Bronchopulmonary Dysplasia(BPD)
Follow-Up Study of Safety and Efficacy of Mesenchymal Stem Cells in Preterm Infants With Moderate or Severe Bronchopulmonary Dysplasia
This is a follow-up study to investigate the long-term safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs), for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the PhaseⅠtrial (NCT03558334 ) will be followed-up until 48 months after the hUC-MSCs transplantation.
100 项与 人脐带间充质干细胞疗法(重庆医科大学附属儿童医院) 相关的临床结果
100 项与 人脐带间充质干细胞疗法(重庆医科大学附属儿童医院) 相关的转化医学
100 项与 人脐带间充质干细胞疗法(重庆医科大学附属儿童医院) 相关的专利(医药)
100 项与 人脐带间充质干细胞疗法(重庆医科大学附属儿童医院) 相关的药物交易